Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Study of Ipilimumab in Women With Metastatic or Recurrent HPV-Related Cervical Carcinoma of Either Squamous Cell or Adenocarcinoma Histologies

NCT01693783 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT01693783
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01693783 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Study of Ipilimumab in Women With Metastatic or Recurrent HPV-Related Cervical Carcinoma of Either Squamous Cell or Adenocarcinoma Histologies
Lead sponsor
National Cancer Institute (NCI)
Phase
Phase 2
Overall status
Completed
Start date
December 3, 2012
Completion date
November 24, 2021
Enrollment
42 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

cervical adenocarcinoma, cervical squamous cell carcinoma, human papillomavirus infection, recurrent cervical carcinoma, stage iva cervical cancer ajcc v6 and v7, stage ivb cervical cancer ajcc v6 and v7